ThredUp Inc vs 22nd Century Group Inc — how do they compare? ThredUp Inc trades at $2.48 (market cap $308.63M), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: ThredUp Inc is far larger — about 496.5× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 3,024,364). Which is the better fit depends on your goals — on Pluang, investors hold ThredUp Inc for 29 Days and 22nd Century Group Inc for 32 Days on average.
| TDUP | XXII | |
|---|---|---|
Market Cap | $308.63M | $621.67K |
Volume | 3,024,364 | 45,625 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $9.41 | $483.00 |
52-Week Low | $2.12 | $0.80 |
Typical Hold Time | 29 Days | 32 Days |
Enterprise Value | $306.81M | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
ThredUp (TDUP) trades at $2.35, up 5.86% today, with a bearish technical signal and mixed financials. Revenue grew to $310.81M in 2025, but net losses persist at -$20.21M, though margins improved. Recent news highlights a record Q2 2026 with 17% revenue growth but also a fraud investigation and lowered guidance, causing volatility. Cash flow turned positive in 2025 at $3.09M, but debt-to-asset ratios remain elevated.
Outlook is cautious; analyst consensus is 57% buy, but profitability challenges and legal risks weigh. The stock faces headwinds from promotional pressures and investor skepticism, though expansion into live shopping offers growth potential. Risks include sustained losses, competitive threats, and macroeconomic sensitivity.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.
Read more on TDUP →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →